Home › Concussion › Texas › San Antonio
Concussion clinical trials in San Antonio, TX
5 studies for Concussion are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
RecruitingPhase 3
- South Texas Health Care System, San Antonio, TX, San Antonio
Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C)
Recruiting
- Brooke Army Medical Center, San Antonio
Auditory Plasticity Training
Recruiting
- The University of Texas Health Science Center at San Antonio, San Antonio
Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation
Recruiting
- Fort Sam Houston, San Antonio
Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)
RecruitingPhase 3
- South Texas Veterans Healthcare System, San Antonio
About Concussion
Concussion, a minor injury to the brain due to a blow or hit to the head. Symptoms may not show up right away. Learn when to see your doctor.
More about Concussion on MedlinePlus
Concussion trials in other cities
- San Diego, CA6 studies
- Philadelphia, PA4 studies
- Washington, DC4 studies
- Pittsburgh, PA4 studies
- Dallas, TX4 studies
- Fayetteville, NC4 studies
- Aurora, CO3 studies
- Minneapolis, MN3 studies
- Durham, NC3 studies
- Seattle, WA3 studies
- Boston, MA3 studies
- Houston, TX3 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Colorectal Cancer46 studies
- Breast Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity40 studies
- Type 2 Diabetes37 studies
- Overweight34 studies
- Ovarian Cancer31 studies
- Pancreatic Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.